HYPERION DEFI, INC. Earnings Per Share (Basic)
HYPERION DEFI, INC. (HYPD) reported Earnings Per Share (Basic) of $1.01 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- HYPERION DEFI, INC. earnings per share, basic for the quarter ending 2026-06-30 was $1.01.
- HYPERION DEFI, INC. earnings per share, basic for the quarter ending 2026-03-31 was $0.30.
- HYPERION DEFI, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$4.94.
- HYPERION DEFI, INC. earnings per share, basic for the quarter ending 2025-09-30 was $0.26.
- HYPERION DEFI, INC. earnings per share, basic for fiscal 2025 was -$9.40.
- HYPERION DEFI, INC. earnings per share, basic for fiscal 2024 was -$59.81.
- HYPERION DEFI, INC. earnings per share, basic for fiscal 2023 was -$53.15.
- HYPERION DEFI, INC. earnings per share, basic for fiscal 2022 was -$0.83.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.01 10-Q · filed 2026-08-13 | $1.36 10-Q · filed 2026-08-13 | -$2.09 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.19 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2026-03-31 | $0.30 10-Q · filed 2026-05-15 | -$3.97 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$4.32 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$6.28 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-12-31 | -$4.94 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$5.48 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$8.07 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$9.40 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $0.26 10-Q · filed 2025-11-14 | -$1.51 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.64 10-Q · filed 2025-11-14 | -$9.47 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-06-30 | -$2.50 10-Q · filed 2026-08-13 | -$4.29 10-Q · filed 2026-08-13 | -$13.97 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$20.59 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-03-31 | -$1.59 10-Q · filed 2026-05-15 | -$13.77 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$22.00 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$34.34 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||||
| 2024-12-31 | -$16.44 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$26.73 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$42.47 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$59.81 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | -$9.07 10-Q · filed 2025-11-14 | -$0.11 10-Q · filed 2024-11-12 | -$24.70 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$42.30 10-Q · filed 2025-11-14 | -$0.53 10-Q · filed 2024-11-12 | $1.36 derived: net income ÷ weighted average shares · filed 2025-11-14 | ||
| 2024-06-30 | -$16.65 10-Q · filed 2025-08-13 | -$0.21 10-Q · filed 2024-08-14 | -$35.26 10-Q · filed 2025-08-13 | -$0.44 10-Q · filed 2024-08-14 | $0.80 derived: net income ÷ weighted average shares · filed 2025-08-13 | $2.06 derived: net income ÷ weighted average shares · filed 2025-08-13 | ||
| 2024-03-31 | -$18.75 10-Q · filed 2025-05-19 | -$0.23 10-Q · filed 2024-05-15 | $0.33 derived: net income ÷ weighted average shares · filed 2025-05-19 | $1.08 derived: net income ÷ weighted average shares · filed 2025-05-19 | $3.73 derived: net income ÷ weighted average shares · filed 2025-05-19 | |||
| 2023-12-31 | $0.07 derived: net income ÷ weighted average shares · filed 2025-04-15 | $0.42 derived: net income ÷ weighted average shares · filed 2025-04-15 | $1.82 derived: net income ÷ weighted average shares · filed 2025-04-15 | -$53.15 10-K · filed 2025-04-15 | -$0.66 10-K · filed 2024-03-18 | |||
| 2023-09-30 | -$0.18 10-Q · filed 2024-11-12 | -$0.35 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.50 10-Q · filed 2024-11-12 | -$0.67 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||||
| 2023-06-30 | -$0.16 10-Q · filed 2024-08-14 | -$0.32 10-Q · filed 2024-08-14 | -$0.49 derived: net income ÷ weighted average shares · filed 2024-08-14 | -$0.69 derived: net income ÷ weighted average shares · filed 2024-08-14 | ||||
| 2023-03-31 | -$0.15 10-Q · filed 2024-05-15 | -$0.32 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$0.53 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$0.74 derived: net income ÷ weighted average shares · filed 2024-05-15 | ||||
| 2022-12-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2024-03-18 | -$0.38 derived: net income ÷ weighted average shares · filed 2024-03-18 | -$0.59 derived: net income ÷ weighted average shares · filed 2024-03-18 | -$0.83 10-K · filed 2024-03-18 | ||||
| 2022-09-30 | -$0.21 10-Q · filed 2023-11-13 | -$0.43 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.67 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | -$0.22 10-Q · filed 2023-08-11 | -$0.46 10-Q · filed 2023-08-11 | ||||||
| 2022-03-31 | -$0.24 10-Q · filed 2023-05-12 | |||||||
| 2021-12-31 | -$0.49 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | -$0.21 10-Q · filed 2022-11-14 | -$0.61 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.19 10-Q · filed 2022-08-11 | -$0.40 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | -$0.21 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | -$0.94 10-K · filed 2022-03-30 | |||||||
| 2020-09-30 | -$0.23 10-Q · filed 2021-11-12 | -$0.79 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |